Company Overview of Merck Sharp & Dohme B.V.
Merck Sharp & Dohme B.V. produces, packs, and sends medicines to more than 140 countries. The company produces medicines for diabetes, high blood pressure, migraines, high cholesterol, osteoporosis, pain, and rheumatic diseases. Merck Sharp & Dohme B.V. was founded in 1954 and is based in Haarlem, the Netherlands. Merck Sharp & Dohme B.V. operates as a subsidiary of Merck & Co. Inc.
Founded in 1954
31 23 515 3153
31 23 514 8000
Key Executives for Merck Sharp & Dohme B.V.
Compensation as of Fiscal Year 2015.
Merck Sharp & Dohme B.V. Key Developments
Forest Laboratories Holdings Limited Partners with Merck Sharp & Dohme B.V
Dec 6 13
Forest Laboratories Holdings Limited has agreed to partner with Merck Sharp & Dohme B.V., under which, Forest Laboratories will acquire from Merck the exclusive marketing rights in the US for Saphris(R) (asenapine) sublingual tablets, a treatment for adult patients with schizophrenia or acute bipolar mania. Under the terms of the agreement, Forest Laboratories will make an upfront payment of $240 million and additional payments to Merck based on defined sales milestones. As a part of the agreement, Merck will responsible for product supply. Forest Laboratories will responsible for continued commercialization, including completing certain post marketing studies of Saphris following a transition period, and will be the marketing authorization holder. The agreement is expected to close in early 2014 pending regulatory review and satisfaction of all closing conditions. The transaction will allow Forest Laboratories to gain access to another commercial product in the central nervous system (CNS) category, and also gives access to the schizophrenia segment to work towards registering and commercializing cariprazine. It will also allow Merck to focus on both research and development (R&D) and commercial resources on other opportunities, while complementing Forest Laboratories' product portfolio and allowing for continued access to Saphris for physicians and patients.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries